• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Frontiers in hepatic drug delivery-grand challenges.

作者信息

Lanao José M

机构信息

Pharmaceutical Sciences Department, Area of Pharmacy and Pharmaceutical Technology, Institute for Biomedical Research of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain.

出版信息

Front Drug Deliv. 2023 Oct 20;3:1265446. doi: 10.3389/fddev.2023.1265446. eCollection 2023.

DOI:10.3389/fddev.2023.1265446
PMID:40838065
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12363291/
Abstract
摘要

相似文献

1
Frontiers in hepatic drug delivery-grand challenges.肝脏药物递送前沿——重大挑战
Front Drug Deliv. 2023 Oct 20;3:1265446. doi: 10.3389/fddev.2023.1265446. eCollection 2023.
2
3D printing combined with biopredictive dissolution and PBPK/PD modeling optimization and personalization of pharmacotherapy: Are we there yet?3D 打印技术结合生物预测溶解和 PBPK/PD 建模优化与个体化药物治疗：我们做到了吗？
Drug Discov Today. 2023 Oct;28(10):103731. doi: 10.1016/j.drudis.2023.103731. Epub 2023 Aug 2.
3
Development of PBPK Population Model for End-Stage Renal Disease Patients to Inform OATP1B-, BCRP-, P-gp-, and CYP3A4-Mediated Drug Disposition with Individual Influencing Factors.用于终末期肾病患者的PBPK群体模型的开发，以了解OATP1B、BCRP、P-糖蛋白和CYP3A4介导的药物处置及个体影响因素。
Pharmaceutics. 2025 Aug 20;17(8):1078. doi: 10.3390/pharmaceutics17081078.
4
Opportunities and Challenges of Hepatic Impairment Physiologically Based Pharmacokinetic Modeling in Drug Development-An IQ Perspective.肝损伤生理药代动力学模型在药物研发中的机遇与挑战——IQ视角
Clin Pharmacol Ther. 2025 Jun;117(6):1682-1686. doi: 10.1002/cpt.3601. Epub 2025 Feb 23.
5
Innovative Pharmaceutical Techniques for Paediatric Dosage Forms: A Systematic Review on 3D Printing, Prilling/Vibration and Microfluidic Platform.创新型儿科药物剂型的制药技术：3D 打印、制粒/振动和微流控平台的系统评价。
J Pharm Sci. 2024 Jul;113(7):1726-1748. doi: 10.1016/j.xphs.2024.04.001. Epub 2024 Apr 4.
6
Translational PBPK/PD modeling in drug discovery: A CRO perspective.药物研发中的转化型PBPK/PD建模：CRO视角
Drug Discov Today. 2025 Aug;30(8):104427. doi: 10.1016/j.drudis.2025.104427. Epub 2025 Jul 8.
7
Current 3D Printing Technologies and Their Potential Applications in Drug Delivery, Personalized Medicine & Pharmaceutical Sciences.当前的3D打印技术及其在药物递送、个性化医疗和制药科学中的潜在应用。
Curr Drug Discov Technol. 2025 Aug 22. doi: 10.2174/0115701638392138250722112310.
8
Physiologically-Based Pharmacokinetics and Empirical Pharmacodynamic Modeling for Pediatric Henagliflozin Dosing: Clinical Insights for Chinese Patients.基于生理学的儿童恩格列净给药药代动力学和经验药效学建模：对中国患者的临床见解
Pediatr Diabetes. 2025 Aug 7;2025:8857248. doi: 10.1155/pedi/8857248. eCollection 2025.
9
Trends in Photopolymerization 3D Printing for Advanced Drug Delivery Applications.用于先进药物递送应用的光聚合3D打印技术趋势
Biomacromolecules. 2025 Jan 13;26(1):85-117. doi: 10.1021/acs.biomac.4c01004. Epub 2024 Dec 3.
10
3D printed metamaterials: properties, fabrication, and drug delivery applications.3D打印超材料：特性、制造及药物递送应用
Adv Drug Deliv Rev. 2025 Jun 9;224:115636. doi: 10.1016/j.addr.2025.115636.

本文引用的文献

1
Nanoparticles in NAFLD therapeutics.非酒精性脂肪性肝病治疗中的纳米颗粒
Nat Rev Gastroenterol Hepatol. 2023 Jul;20(7):414. doi: 10.1038/s41575-023-00797-w.
2
Exosome-loaded scaffolds for regenerative medicine in hard tissues.负载外泌体的支架在硬组织再生医学中的应用。
Tissue Cell. 2023 Jun;82:102102. doi: 10.1016/j.tice.2023.102102. Epub 2023 May 2.
3
Organs-on-chips technologies - A guide from disease models to opportunities for drug development.器官芯片技术——从疾病模型到药物开发机遇的指南。
Biosens Bioelectron. 2023 Jul 1;231:115271. doi: 10.1016/j.bios.2023.115271. Epub 2023 Mar 31.
4
Emerging role of engineered exosomes in nonalcoholic fatty liver disease.工程化外泌体在非酒精性脂肪性肝病中的新兴作用。
World J Hepatol. 2023 Mar 27;15(3):386-392. doi: 10.4254/wjh.v15.i3.386.
5
Insights on drug and gene delivery systems in liver fibrosis.肝纤维化中药物和基因递送系统的见解
Asian J Pharm Sci. 2023 Mar;18(2):100779. doi: 10.1016/j.ajps.2023.100779. Epub 2023 Jan 29.
6
The impact of drug-eluting bead (vs. conventional) transarterial chemoembolization on hepatic fibrosis in treating intermediate or advanced hepatocellular carcinoma.药物洗脱微球（与常规相比）经动脉化疗栓塞治疗中晚期肝细胞癌对肝纤维化的影响。
Cancer Biol Ther. 2023 Dec 31;24(1):2166335. doi: 10.1080/15384047.2023.2166335.
7
Hepatocytes: A key role in liver inflammation.肝细胞：肝脏炎症中的关键角色。
Front Immunol. 2023 Jan 18;13:1083780. doi: 10.3389/fimmu.2022.1083780. eCollection 2022.
8
Recent Advances in Stimuli-Responsive Doxorubicin Delivery Systems for Liver Cancer Therapy.用于肝癌治疗的刺激响应性阿霉素递送系统的最新进展
Polymers (Basel). 2022 Dec 1;14(23):5249. doi: 10.3390/polym14235249.
9
Strategies for 3D bioprinting of spheroids: A comprehensive review.球形聚集体的 3D 生物打印策略：全面综述。
Biomaterials. 2022 Dec;291:121881. doi: 10.1016/j.biomaterials.2022.121881. Epub 2022 Oct 28.
10
A Comprehensive Review on Liver Targeting: Emphasis on Nanotechnology- based Molecular Targets and Receptors Mediated Approaches.肝脏靶向的综合评价：重点介绍基于纳米技术的分子靶点和受体介导的方法。
Curr Drug Targets. 2022;23(15):1381-1405. doi: 10.2174/1389450123666220906091432.